Sirolimus brand name
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Sirolimus Brand Name: Rapamune
Introduction to Sirolimus (Rapamycin)
Sirolimus, also known by its generic name rapamycin, is a natural product derived from the bacterium Streptomyces hygroscopicus, which was discovered in a soil sample from Easter Island, also known as Rapa Nui . This compound has garnered significant attention due to its multifaceted biological properties, including antifungal, antitumor, and immunosuppressive activities .
Mechanism of Action and Clinical Applications
Immunosuppressive Properties
Sirolimus is a potent immunosuppressant that works by forming a complex with the intracellular protein FKBP12, which then inhibits the mammalian target of rapamycin (mTOR), a key kinase involved in cell cycle progression . This inhibition effectively blocks the proliferation of T cells and B cells, making sirolimus highly effective in preventing organ transplant rejection . Clinical trials have demonstrated its efficacy in reducing acute rejection episodes in renal transplant patients when used in combination with other immunosuppressive agents like cyclosporine A (CsA) and steroids .
Antitumor and Antifungal Activities
Initially isolated for its antifungal properties, sirolimus was later found to have significant antitumor activities. It has shown effectiveness against various murine tumors, including melanocarcinoma and colon tumors. The same mTOR inhibition mechanism that provides its immunosuppressive effects also contributes to its antiproliferative properties, making it a valuable agent in cancer therapy.
Sirolimus in Coronary Artery Disease
Sirolimus-Eluting Stents
One of the notable applications of sirolimus is in the prevention of in-stent restenosis in coronary arteries. Sirolimus-eluting stents have been developed to release the drug slowly, thereby inhibiting the proliferation of vascular smooth muscle cells and reducing the risk of restenosis, a common complication following angioplasty . This application has significantly impacted the management of coronary artery disease, offering a new avenue for improving patient outcomes.
Brand Name: Rapamune
Sirolimus is marketed under the brand name Rapamune by Wyeth-Ayerst Laboratories. Rapamune has become a cornerstone in long-term immunosuppressive therapy for renal transplantation due to its unique mechanism of action and favorable safety profile compared to other immunosuppressants like cyclosporine .
Conclusion
Sirolimus, or Rapamune, is a versatile drug with a broad spectrum of applications ranging from immunosuppression in organ transplantation to the prevention of coronary artery restenosis. Its discovery from a soil sample on Easter Island has led to significant advancements in medical treatments, making it a critical component in modern therapeutic regimens.
Sources and full results
Most relevant research papers on this topic